Table 4.
White non-Hispanic | White Hispanic | Black | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Intron 2 VNTR |
Remission | N | P- Value(2)) |
P- Value(3)) |
Remission | N | P- Value(2)) |
P- Value(3)) |
Remission | N | P- Value(2)) |
P- Value(3)) |
9/10 | 52.9% | 17 | 0.810 | 1.000 | 0% | 1 | 1.000 | 1.000 | ||||
9/12 | 70.6% | 17 | 0.088 | 0.353 | 100% | 1 | 0.374 | 1.000 | ||||
10/10 | 55.7% | 158 | 0.070 | 0.282 | 29.2% | 24 | 0.500 | 1.000 | 35.3% | 17 | 1.000 | 1.000 |
10/12 | 49.9% | 469 | 0.619 | 1.000 | 38.5% | 78 | 0.880 | 1.000 | 37.9% | 95 | 1.000 | 1.000 |
12/12 | 44.1% | 381 | 0.017 | 0.069 | 38.5% | 91 | 0.882 | 1.000 | 37.9% | 116 | 1.000 | 1.000 |
Global P- Value(1)) |
0.041 | 0.670 | 1.000 | |||||||||
Indel Promoter |
Remission | N | P- Value(2)) |
P- Value(3)) |
Remission | N | P- Value(2)) |
P- Value(3)) |
Remission | N | P- Value(2)) |
P- Value(3)) |
L/L | 53.7% | 369 | 0.012 | 0.024 | 31.7% | 60 | 0.267 | 0.533 | 37.8% | 143 | 0.780 | 1.000 |
L/S | 45.2% | 504 | 0.058 | 0.115 | 39.8% | 83 | 0.656 | 1.000 | 41.6% | 77 | 0.567 | 1.000 |
S/S | 46.2% | 195 | 0.527 | 1.000 | 41.5% | 53 | 0.512 | 1.000 | 30% | 10 | 0.744 | 1.000 |
Global P- Value(1)) |
0.039 | 0.490 | 0.787 | |||||||||
rs25531 | Remission | N | P- Value(2)) |
P- Value(3)) |
Remission | N | P- Value(2)) |
P- Value(3)) |
Remission | N | P- Value(2)) |
P- Value(3)) |
A/A | 47.6% | 925 | 0.134 | 0.267 | 38.5% | 174 | 0.644 | 1.000 | 38.9% | 126 | 0.893 | 1.000 |
A/G | 54.5% | 145 | 0.129 | 0.259 | 35% | 20 | 1.000 | 1.000 | 38.3% | 94 | 1.000 | 1.000 |
G/G | 50% | 4 | 1.000 | 1.000 | 0% | 2 | 0.528 | 1.000 | 33.3% | 12 | 1.000 | 1.000 |
Global P- Value(1)) |
0.287 | 0.752 | 0.975 |
Fisher’s exact test comparing remission rates across all genotypes.
Fisher’s exact test comparing each genotype versus all others in a 2x2 table; not corrected for multiple testing.
Corrected for multiple testing by multiplying Fisher’s P-value by the number of independent genotype tests.